Trial NCT02580708

View at ClinicalTrials.gov 
Org. Study IDs: CO-1686-033

Last trial update was posted on 2018-10-02

MeSH Interventions

Trametinib

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non-small Cell Lung Cancer

Stopping Reasons

Discontinued development of rociletinib in NSCLC. Stopped enrollment of new patients into all studies involving rociletinib.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID